Exorna Bioscience
Clinical trials sponsored by Exorna Bioscience, explained in plain language.
-
New Huntington's drug enters human testing
Disease control OngoingThis early-stage study is testing a new injection called ER2001 in people with early Huntington's disease. The main goals are to check if the treatment is safe, how the body processes it, and to look for early signs it might help. Participants receive weekly injections for 6 week…
Phase: PHASE1, PHASE2 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New Huntington's drug enters next safety check
Disease control OngoingThis is a very early study to check the safety of a new drug called ER2001 for people with early Huntington's disease. It will give 9 participants who were in a previous study weekly injections for 6 weeks to see how their bodies handle the drug and if there are any side effects.…
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC